Download this document to view the Adapta™ DR pacing system specifications sheet.
Pacemakers
Adapta™ pacemaker
<p>The Adapta™ pacing system includes pacing with automaticity.</p>
Ordering information
| Item number | Description | Volume (mL) | Size — height × width × depth (mm) |
Connector | Battery type / voltage |
|---|---|---|---|---|---|
| ADDR01 | Adapta™ DR | 12.1 | 44.7 × 47.9 × 7.5 | IS-1 BI or UNI | Lithium-iodine / 2.8V |
| ADDR03 | Adapta™ DR | 13.0 | 46.7 × 47.9 × 7.5 | 3.2 mm LP BI, IS-1 BI, or UNI | Lithium-iodine / 2.8V |
| ADDR06 | Adapta™ DR | 14.2 | 50.3 × 47.9 × 7.5 | 5 or 6 mm UNIa | Lithium-iodine / 2.8V |
| ADDRS1 | Adapta™ DR | 11.1 | 44.7 × 42.9 × 7.5 | IS-1 BI or UNI | Lithium-iodine / 2.8V |
| ADDRL1 | Adapta™ DR | 13.1 | 45.4 × 52.3 × 7.5 | IS-1 BI or UNI | Lithium-iodine / 2.8V |
| ADD01 | Adapta™ D | — | — | — | — |
| ADVDD01 | Adapta™ VDD | 11.1 | 44.7 × 42.9 × 7.5 | IS-1 BI or UNI | Lithium-iodine / 2.8V |
| ADSR01 | Adapta™ SR | 9.7 | 40.2 × 42.9 × 7.5 | IS-1 BI or UNI | Lithium-iodine / 2.8V |
| ADSR03 | Adapta™ SR | 10.5 | 42.9 × 42.9 × 7.5 | 3.2 mm LP BI, IS-1 BI, or UNI | Lithium-iodine / 2.8V |
| ADSR06 | Adapta™ SR | 11.0 | 43.3 × 42.9 × 7.5 | 5 or 6 mm UNI† | Lithium-iodine / 2.8V |
† Parylene coating on backside of case
Resources
Similar products
-
Advisa™ MRI SureScan™ pacemakerAdvisa™ MRI SureScan™ implantable pacing generators (IPGs) are approved for 1.5T and 3T full-body MRI scans.
-
Azure™ MRI SureScan™ pacemakerThe Azure™ MRI SureScan™ pacemaker manages atrial fibrillation (AF) in pacemaker patients with tablet-based programming and app-based remote monitoring.
-
Micra™ AV2 leadless pacemakerMicra™ AV2 provides an unmatched leadless pacing experience for patients with bradycardia.
-
Micra™ VR2 leadless pacemakerMicra™ VR2 provides an unmatched leadless pacing experience for patients with bradycardia.
- Gillis A, Pürerfellner H, Israel C, et al. Reduction of unnecessary ventricular pacing due to the managed ventricular pacing (MVP) mode in pacemaker patients: Benefit for both sinus node disease (SND) and AV block (AVB) indications. Presented at HRS 2005 (Abstract AB21-1).
- Anderson HR, et al. Lancet. 1997;350:1210–1216.
- Skanes AC, et al. J Am Coll Cardiol. 2001;38:167–172.
- Neilsen J, et al. J Am Coll Cardiol. 2003;42:614–623.
- Sweeney M, et al. Circulation. 2003;107:2932–2937.